PATENT CLAIM ANALYSIS

Application Number: 16046429
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "231100"]

Abstract:
The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting Herpes Simplex Virus (HSV) nucleic acid (e.g., HSV-1 and/or HSV-2 nucleic acid). Compositions include amplification oligomers, detection probe oligomers and/or target capture oligomers. Kits and methods comprise at least one of these oligomers.

Claim (Index 36):
A composition comprising at least four oligomers for determining the presence or absence of Herpes Simplex Virus 1 (HSV-1) and Herpes Simplex Virus 2 (HSV-2) in a sample, said oligomer combination comprising:\n first and second amplification oligomers for amplifying a target region of an HSV-1 target nucleic acid, wherein\n (a) a first amplification oligomer comprising a first target-hybridizing sequence that is from about 15 to about 27 contiguous nucleotides contained in the sequence of SEQ ID NO:31 and that includes at least the sequence of SEQ ID NO:30; and \n (b) a second amplification oligomer comprising a second target-hybridizing sequence that is from about 15 to about 27 contiguous nucleotides contained in the sequence of SEQ ID NO:33 and that includes at least the sequence of SEQ ID NO:32; \n and third and fourth amplification oligomers for amplifying a target region of an HSV-2 target nucleic acid, wherein\n (c) the third amplification oligomer comprises a third target-hybridizing sequence that is from about 15 to about 27 contiguous nucleotides (i) contained in the sequence of SEQ ID NO:49 and that includes at least the sequence of SEQ ID NO:48 or (ii) contained in the sequence of SEQ ID NO:43 and that includes at least the sequence of SEQ ID NO:42; and \n (d) the fourth amplification oligomer comprises a fourth target-hybridizing sequence that is from about 15 to about 27 contiguous nucleotides (i) contained in the sequence of SEQ ID NO:51 and that includes at least the sequence of SEQ ID NO:50 or (ii) contained in the sequence of SEQ ID NO:45 and that includes at least the sequence of SEQ ID NO:44.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.39535
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15487240', '14395039', '14441815', '13642428', '14113880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7803363530390787
- 35 USC 102 Novelty (BERT): 0.5685749343859239
- Combined Prediction Score: 0.7591602111737632
- Mean Citation Score: 417.629316
- Max Citation Score: 471.57626
- Similarity Product: 392.6657615858769

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test